AI assistant
Sending…
IO Biotech, Inc. — Director's Dealing 2024
May 15, 2024
34883_dirs_2024-05-14_971d9f96-e10a-441a-b32c-7887c174e5c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2024-05-10
Reporting Person: Novo Holdings A/S (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-10 | COMMON STOCK | S | 658809 | $1.2181 | Disposed | 4429449 | Direct |
More from IO Biotech, Inc.
Regulatory Filings
2026
Mar 31
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 13
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Jan 30
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2026
Jan 21
Regulatory Filings
2025
Dec 19
Regulatory Filings
2025
Nov 21
Regulatory Filings
2025
Nov 18